{"address1": "3-5-1, Nihonbashi-honcho", "address2": "Chuo-ku", "city": "Tokyo", "zip": "103-8426", "country": "Japan", "phone": "81 3 6225 1111", "website": "https://www.daiichisankyo.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Daiichi Sankyo Company, Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; and ferric carboxymaltose injection for treating anemia. It also provides edoxaban, an oral, once-daily, direct factor Xa inhibitor; esaxerenone and olmesartan medoxomil antihypertensive agents; NILEMDO, an oral treatment to help in lowering cholesterol; and Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe for reducing cholesterol. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgality for the treatment of migraine attacks; Pralia for the treatment of osteoporosis/inhibitor of the progression of bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications caused by bone metastases from tumors; Tarlige for treating pain; Tenelia for the treatment of Type 2 diabetes mellitus; Venofer for the treatment of iron deficiency anemia; and Vimpat, an anti-epileptic agent. Further, it provides vaccines for influenza, measles/rubella infection, and mumps. The company was founded in 1899 and is headquartered in Tokyo, Japan.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Sunao  Manabe D.V.M., Ph.D.", "age": 68, "title": "Group CEO & Exec. Chairperson", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": 2050908, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Masahiko  Ohtsuki", "age": 63, "title": "Sr. Exec. Officer, Head of Global DX, Chief Digital Transformation Officer & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 792228, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shoji  Hirashima", "age": 61, "title": "Sr. Exec. Officer, Head of Japan Bus. Unit & Director", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": 807036, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hiroyuki  Okuzawa", "age": 60, "title": "Pres, COO & Representative Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Koji  Ogawa", "title": "Exec. Officer, Head of Global Corp. Planning and Management & CFO", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Naoto  Tsukaguchi", "title": "Gen. Counsel, Corp. Officer, Head of Global Leg., IP, Global Compl. and Risk & VP of Leg. Aff. Dept.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Kentaro  Asakura", "title": "VP of Corp. Communications Department", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Marielle  Cohard-Radice M.D.", "title": "Global Head of Devel.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Akio  Sakurai", "title": "Corp. Officer, Head of Sales and Marketing Div. & Japan Bus. Unit", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Takashi  Matsumoto", "title": "Exec. Officer, Head of Global HR & Chief HR Officer", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 1, "boardRisk": 1, "compensationRisk": 2, "shareHolderRightsRisk": 2, "overallRisk": 1, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 33.77, "open": 33.33, "dayLow": 33.25, "dayHigh": 33.49, "regularMarketPreviousClose": 33.77, "regularMarketOpen": 33.33, "regularMarketDayLow": 33.25, "regularMarketDayHigh": 33.49, "dividendRate": 0.25, "dividendYield": 0.0075, "exDividendDate": 1695859200, "payoutRatio": 0.9211, "beta": 0.45764, "trailingPE": 144.56522, "forwardPE": 36.53846, "volume": 946, "regularMarketVolume": 946, "averageVolume": 13435, "averageVolume10days": 5860, "averageDailyVolume10Day": 5860, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 64823205888, "fiftyTwoWeekLow": 22.16, "fiftyTwoWeekHigh": 36.73, "priceToSalesTrailing12Months": 0.05070342, "fiftyDayAverage": 34.2986, "twoHundredDayAverage": 31.4476, "trailingAnnualDividendRate": 30.0, "trailingAnnualDividendYield": 0.88836247, "currency": "USD", "enterpriseValue": -234084302848, "profitMargins": 0.0854, "floatShares": 1916960406, "sharesOutstanding": 1916790016, "heldPercentInsiders": 0.014450001, "heldPercentInstitutions": 0.5658, "impliedSharesOutstanding": 0, "bookValue": 754.092, "priceToBook": 0.044092763, "lastFiscalYearEnd": 1680220800, "nextFiscalYearEnd": 1711843200, "mostRecentQuarter": 1680220800, "netIncomeToCommon": 109187997696, "trailingEps": 0.23, "forwardEps": 0.91, "pegRatio": 25071.4, "lastSplitFactor": "3:1", "lastSplitDate": 1601337600, "enterpriseToRevenue": -0.183, "enterpriseToEbitda": -1.243, "52WeekChange": 0.3661003, "SandP52WeekChange": 0.046755195, "lastDividendValue": 0.113, "lastDividendDate": 1680134400, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "DSKYF", "underlyingSymbol": "DSKYF", "shortName": "DAIICHI SANKYO COMPANY LIMITED", "longName": "Daiichi Sankyo Company, Limited", "firstTradeDateEpochUtc": 1214314200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "30a463fe-e9b3-3fc1-b0c4-ff1992a19a68", "messageBoardId": "finmb_23697721", "gmtOffSetMilliseconds": -14400000, "currentPrice": 33.25, "targetHighPrice": 40.88, "targetLowPrice": 40.88, "targetMeanPrice": 40.88, "targetMedianPrice": 40.88, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 441921011712, "totalCashPerShare": 230.486, "ebitda": 188371992576, "totalDebt": 143087992832, "quickRatio": 1.492, "currentRatio": 2.819, "totalRevenue": 1278477991936, "debtToEquity": 9.896, "revenuePerShare": 666.904, "returnOnAssets": 0.03186, "returnOnEquity": 0.07808, "freeCashflow": -185855623168, "operatingCashflow": 114514001920, "revenueGrowth": 0.412, "grossMargins": 0.71566004, "ebitdaMargins": 0.14734, "operatingMargins": 0.09432, "financialCurrency": "JPY", "trailingPegRatio": 1.3003}